Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Presentation

<< Previous

Bullboard Posts

Next >>

Comment by Redbaron2211on Apr 08, 2021 4:17pm

114 Views

Post# 32958575

RE:RE:RE:RE:RE:Presentation

Seems pretty involved for most shareholders I would call it an unlikely option especially at this juncture when the important information is held up in NDA's. If I don't like management I move on. Most investors/institutions I talk with are happy with Philip and optimistic so it seems there are obvious inconsistencies among those that hold large portions of the company. I guess the only way to find out would be a vote. Re AGM I was referring to the chance they are bought out.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario